Nevertheless, it was showed that HTR2B was downregulated in invasive ductal breast carcinoma with a FC of 2.567 (The Radvanyi Breast Statistics), intraductal cribriform breast adenocarcinoma with a FC of 4.579 and mucinous breast carcinoma with a FC of 2.455 (TCGA breast statistics). This evidence concerns the gene HTR2B and invasive ductal breast carcinoma.